conference logo
 
Programme  Titles  Presenters 
10th EACPT Summer School
Day, theme etc., 4-6 July 2013
Royal College of Physicians of Edinburgh
All posters should be displayed throughout the whole meeting. Poster presenters with ODD poster numbers will be asked to stand by their poster during the scheduled poster session on Thursday 4th July 2013 and presenters with EVEN poster numbers will be presenting on Friday 5th July 2013.
P001 Protective Effect of Trace Elements and Their Combination on Isoprenaline-Induced Myocardial Structural Alterations
Nouf AL-Rasheed*, Nawal AL-Rasheed, Hala Attia, Iman Hassan, Hanaa AL-Ajmi, Maha AL-Amin, Raessa Ahmed
King Saud University, Saudi Arabia
P002 Cardiac patients are very prone to toxicity with potentially nephrotoxic antibiotics commonly used: Case series demonstration.
H Tesfaye
Department of Medical Chemistry and Clinical Biochemistry, Division of Clinical Pharmacology, Faculty Hospital in Motol, 2nd Faculty of Medicine, Charles University, Czech Republic
P003 Effect of ethanol- extract of Cucurbita ficifolia  on blood glucose, lipids and lipoproteins in diabetic rats with alloxan - monohydrate
Mehrdad Pashazadeh
Department of Biology, Islamic Azad University of Ahar–Iran, young researchers Club, Iran
P004 Investigtion into early mortality in Malawian adults treated for pulmonary tuberculosis
CJ Waitt*1,2, NPK Banda2,3, SA White2, B Kampmann5, J Kumwenda2, RS Heyderman2,4, M Pirmohamed1, SB Squire4
1University of Liverpool, UK, 2Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi, 3Department of Medicine, College of Medicine, Malawi, 4Liverpool School of Tropical Medicine, UK, 5Imperial College London, UK
P005 Carbamazepine Hypersensitivity: Linking Metabolism to the Immune Response
Vincent Yip*, Anthony Marson, Munir Pirmohamed
University of Liverpool, UK
P006 HMGB1: A Novel Mechanistic Biomarker in Epilepsy
LE Walker*1, K Tse1, GJ Sills1, DJ Antoine1, T Thippeswamy2, AG Marson1, M Pirmohamed1
1The Wolfson Centre for Personalised Medicine, University of Liverpool, UK, 2College of Veterinary Medicine, IOWA State University, USA
P008 A PK model to predict the impact of antibody enhancement technologies
Daren Austin*, Alienor Berges, Chao Chen
GSK, UK
P012 Evaluation of Therapeutic Choices for the Treatment of Pain in the Terminal Oncologic Patient Before and During Hospice Admission
Julia Daragjati*3, Umberto Gallo2,3, Modesto Zago1, Anna Maria Grion2
1Hospice Paolo VI, Italy, 2Assistenza Farmaceutica ULSS 16, Italy, 3Universitā degli Studi di Padova, Italy
P013 Involvement of Residents in The National Guideline Development Process in Estonia
Madli Pintson*1,2, Alar Irs2,3
1Tartu University Hospital, Estonia, 2Division of Clinical Pharmacology, University of Tartu, Estonia, 3State Agency of Medicines, Estonia
P014 Frequency and nature of prescribing errors made by final year medical students
Andrew Hitchings*, Dagan Lonsdale, Emma Baker
St George's, University of London, UK
P015 What is pharmacovigilance? Who on earth are the MHRA?
FF Schwartz, IA Selvanathar, AW Hitchings, CW Wells, EH Baker, DO Lonsdale*
St George's University, London, UK
P016 Associations of Liver Biochemistry on Long-Term Blood Pressure Control and Mortality in Hypertensive Patients
L McCallum*, P Jeemon, CE Hastie, J Hewitt, R Patel, C Williamson, J Dawson, GC Jones, S Muir, M Walters, D Morrison, AF Dominczak, GT McInnes, N Sattar, S Padmanabhan
University of Glasgow, UK
P017 Pharmacokinetics of Paracetamol
Sabita Paudel*, Nuwadatta Subedi
College of Medical sciences, Nepal
P019 Comparison of acute effects of antioxidants against hyperoxia-induced increase in arterial stiffness in healthy humans and in type 2 diabetics
Darko Modun*1, Zoran Vucinovic2, Jonatan Vukovic2, Grgo Gunjaca1, Ana Seselja Perisin1, Darko Duplancic2
1Department of Basic and Clinical Pharmacology, University of Split School of Medicine, Croatia, 2Department of Internal Medicine, University Hospital Split; School of Medicine, University of Split, Croatia
P020 Drug Withdrawals Because of Deaths After Marketing: a Systematic Review
Igho Onakpoya*, Carl Heneghan, Jeffrey K Aronson
University of Oxford, UK
P021 Teaching antimicrobial stewardship based on lessons learned from a study of the prescribing pattern of piperacillin/tazobactam in a tertiary care hospital.  
Ragini Vaishnav*, Radhiya Buridi
Sultan Qaboos University, Oman
P022 Self medication practice in a Nigerian urban population
Olayinka O. Ogunleye
Lagos State University College of Medicine, Nigeria
P023 Screening for radioprotective components of Glycosides and Alcohols from Rhodiola in vitro
Tian-Xiang Ma*, Jiu-Hong Wu, Ning Shi, Hong-Zhu Gong
Department of Pharmacy,306 Hospital of PLA, China
P024 Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
Bei Cao*1, Mengjie Li1, Weibin Zha1, Qijin Zhao1, Rongrong Gu1, Linsheng Liu1, Jian Shi1, Jun Zhou1, Fang Zhou1, Xiaolan Wu1, Zimei Wu2, Jiye Aa1, Guangji Wang1
1Lab of Metabolomics, Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Chile, 2School of Pharmacy, The University of Auckland, New Zealand
P025 Angiogenesis inhibitor dose: Dual function during cancer treatment
Li Pan*1, Yinling Ren1, Yongjing Yang1, Xiaofeng Huang2, Zhendong Liu1, Hanmei Xu3
1Department of Life Science and Technology, China Pharmaceutical University, China, 2Department of Oral Pathology, Nanjing Stamotology Hospital, Affiliated Medical School, Nanjing University, China, 3The Key Laboratory of Modern Chinese Medicines, Ministry of Education,China Pharmaceutical University, China
P026 Influence of Roux-en-Y gastric bypass surgery on the gene expression and microRNA in the small intestine
H Bruckmueller*1, S Oswald2, R Häsler1, K Ludwig3, W Siegmund2, I Cascorbi1
1Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Germany, 2Department of Clinical Pharmacology, University of Greifswald, Germany, 3Department of Surgery, Clinic Südstadt, Germany
P027 Pilot phase of a randomized, cross-over clinical trial, for assessing the hypotensive effect of evening administration of acetylsalicylic acid
Maria Cruz Gomez Fernandez*1, Natalia Burgos Alonso1, Maria Victoria Ruiz Arzalluz2, Maria Luz Rodriguez Ibaņez2, Ricardo San Vicente Blanco2, Gonzalo Grandes1
1Primary Care Research Unit of Biscay, Spain, 2Osakidetza, Spain
P028 "Process of obtaining and description of autologous and generic platelet rich plasma"
Natalia Burgos Alonso*1, Maria Cruz Gomez Fernandez1, Isabel Andia2, Kepa Mirena San sebastian Moreno3, Igone Lobato Garcia3, Igone Hernandez Cabezas3, Jose Luis Lopez Rivas3, Begoņa Rodriguez Rodriguez0
1Primary Care Research Unit of Biscay, Spain, 2Biocruces, Spain, 3Osakidetza, Spain
P029 Aspirin, but not clopidogrel, reduces monocyte plaque content through a modulatory action on endothelial-derived netrin-1 via a COX-dependent epigenetic modification
Gabriella Passacquale*, Alkystis Phinikaridou, Christina Warboys, Alessio Alfieri, Marcelo Andia, Rene Botnar, Albert Ferro
King's College London, UK
P030 Blood monocyte characterization as a novel surrogate marker for atherosclerosis in at-risk asymptomatic patients
Gabriella Passacquale*, Albert Ferro
King's College London, UK
P032 Utility of a bayesian-based assesment tool for the early diagnosis of drug induced liver injury
L Llanos*1, R Moreu1, T Ortin1, S Pascual2, JF Horga1, P Zapater1
1Clinical Pharmacology Section, Hospital general Universitario, Spain, 2Liver Unit, Hospital General Universitario, Spain
P033 Relaxin is a selective renal vasodilator improving renal function in experimental models of cirrhosis and is a potential novel therapy for hepatorenal syndrome in man
VK Snowdon*1, A Pellicoro1, W Mungall2, R Lennen3, A Thomson3, M Jansen3, P Ramachandran1, T Kendall1, J Hughes1, JP Iredale1, JA Fallowfield1
1MRC/Centre for Inflammation Research,Queens Medical Research Institute, University of Edinburgh, UK, 2Biomedical Research Resources, University of Edinburgh, UK, 3BHF/University Centre for Cardiovascular Sciences, University of Edinburgh, UK
P034 Development of experimental nephrotoxicity model in vivo and assessment of its' applicability for stem cell research
Egle Svitojute*1, Romaldas Maciulaitis1,2, Judita Zymantiene1, Justinas Maciulaitis1
1Lithuanian University of Health Sciences, Lithuania, 2Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, Lithuania
P035 An Integrated In Vitro, In Silico and In Vivo Approach to Predict the Importance of CYP2C8 in Imatinib Pharmacokinetics
AM Filppula*1, A Tornio1,2, M Neuvonen1, J Laitila1, M Niemi1,2, PJ Neuvonen1,2, JT Backman1,2
1University of Helsinki, Finland, 2HUSLAB, Helsinki University Central Hospital, Finland
P036 Making the case for a clinical pharmacology skills program during the preclinical years: A proposal
Lazara Montane Jaime*1, Solomon Senok2
1The University of the West Indies, Trinidad and Tobago, 2College of Medicine, Alfaisal University, Saudi Arabia
P037 Cyclosporine therapeutic window evaluation by Chebyshev’s inequality method in kidney recipients
Aurelija Noreikaite*1, Franck Saint-Marcoux2,1, Edgaras Stankevicius1, Edmundas Kadusevicius1
1Lithuania university of health sciences, Lithuania, 2Department of Pharmacology and Toxicology, CHU Limoges, France
P038 Analysis of common pharmacokinetic and pharmacodynamic gene polymorphisms in a sample of Bulgarian outpatients with recurrent depression
Diana Pendicheva*1, Gyulnas Dzhebir2, Reni Tzveova2
1Medical University, Bulgaria, 22Molecular Medicine Center, Bulgaria